ArticleJournal of clinical medicine2025

Real-World Lessons with Fremanezumab as the Third Available CGRP Monoclonal Antibody in a Third-Level Hospital: Focus on the Factors Predicting Response.

Marcos Polanco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.